|
acinous cell carcinoma |
|
adenocarcinoma |
|
adenocystic |
|
adjuvant chemotherapy |
|
adjuvant therapy |
|
Adriamycin (doxorubicin hydrochloride) |
|
alkylating agents |
|
alopecia |
|
alveolar |
|
analogue |
|
anaplasia |
|
anemia |
|
antibiotics |
|
antiemetic |
|
antimetabolites |
|
arthralgia |
|
asbestos |
|
asthenia |
|
astrocytoma |
|
basal cell |
|
BCNU (carmustine) |
|
benign |
|
biological response modifier |
|
biological therapy |
|
biopsy |
|
blastoma |
|
bleomycin |
|
bone marrow biopsy |
|
bronchoalveolar carcinoma |
|
bronchogenic carcinoma |
|
bronchoscopy |
|
cancer |
|
carcinogens |
|
carcinoma |
|
carcinoma in situ |
|
CCNU (lomustine) |
|
cellular oncogenes |
|
cervical smear (Pap) |
|
chemotherapy |
|
cisplatin |
|
Clark level 1-5 (for melanoma) |
|
clear cell carcinoma |
|
combination chemotherapy |
|
combination studies |
|
compassionate use |
|
complete remission |
|
complete response |
|
cryosurgery |
|
cystic |
|
cystic tumor |
|
cystocarcinoma |
|
cytotoxic agents |
|
dedifferentiation |
|
dermatitis |
|
differentiation |
|
DNA |
|
dacarbazine (DTIC) |
|
ductal carcinoma |
|
dysplastic |
|
electrocauterization |
|
electron beams |
|
embryonal cell |
|
emesis |
|
en bloc resection |
|
encapsulated |
|
encapsulated epidermoid |
|
excisional biopsy |
|
exenteration |
|
exfoliative cytology |
|
fibrosarcoma |
|
FIGO staging |
|
fluid retention |
|
follicular |
|
fractionation |
|
fulguration |
|
fungating tumor |
|
giant cell carcinoma |
|
grading of tumors |
|
granulocyte |
|
hepatocarcinoma |
|
hepatocellular carcinoma |
|
Hurthle cell carcinoma |
|
hyperplasia |
|
hypersensitivity |
|
immunotherapy |
|
infiltrating ductal |
|
inflammatory |
|
in situ adenocarcinoma |
|
in situ carcinoma |
|
interferon |
|
intermediate |
|
intraductal |
|
invasive |
|
in vitro |
|
in vivo |
|
incisional biopsy |
|
induction therapy |
|
infiltrative |
|
invasive |
|
ionizing radiation |
|
islet cell |
|
Kaposi's sarcoma |
|
large-cell |
|
lenticular |
|
leukocytopenia |
|
leukopenia |
|
localized |
|
lumpectomy |
|
lymphangiography |
|
malignancy |
|
malignant |
|
mammogram |
|
mammography |
|
mastectomy |
|
medullary tumor |
|
metastasis (metastases) |
|
microinvasive |
|
microtubule |
|
mitosis (cell division) |
|
modality |
|
morbidity |
|
mortality rate |
|
mucinous |
|
mucositis |
|
mutagenic |
|
mutation |
|
myxoma |
|
necrotic tumor |
|
neoplasm |
|
neuropathy |
|
neutropenia |
|
neutrophil |
|
nodular |
|
oat cell |
|
oncogene |
|
oncology |
|
osteosarcoma |
|
overall response rate |
|
palliative treatment |
|
pancytopenia |
|
Papanicolaou smear (Pap) |
|
papillary |
|
partial response |
|
pedunculated |
|
peritoneoscopy |
|
pharmacokinetics |
|
phase I clinical trials |
|
phase II clinical trials |
|
phase III clinical trials |
|
plant alkaloids |
|
pleomorphic |
|
polypoid tumor |
|
poorly differentiated |
|
primary |
|
prophylactic |
|
protocol |
|
radiation |
|
radiocurable tumor |
|
radionuclide scans |
|
radioresistant tumor |
|
radiosensitive tumor |
|
radiosensitizer |
|
radiotherapy |
|
rectosigmoid |
|
refractory |
|
relapse |
|
remission |
|
renal |
|
renal cell |
|
resection |
|
resistance (acquired) |
|
response rate |
|
retinoblastoma |
|
ribonucleic acid |
|
RNA |
|
sarcoma |
|
scirrhous |
|
second-line chemotherapy |
|
secondary |
|
serous |
|
sessile |
|
single-agent chemotherapy |
|
small cell |
|
solid tumor |
|
spindle cell |
|
squamous cell |
|
stage |
|
staging laparotomy |
|
steroids |
|
tamoxifen |
|
Taxol (paclitaxel) |
|
Taxotere (docetaxol) |
|
teratocarcinoma |
|
thrombocytopenia |
|
toxicity |
|
transitional cell |
|
tubular |
|
tubulin |
|
tumor marker |
|
ulcerating tumor |
|
villous |
|
vinblastine |
|
vincristine |
|
viral oncogenes |
|
Wilms' tumor |